Saturday, September 24, 2022

Passive Income in Q3 2022 and first 9 months of 2022

With a blink of an eye, almost 9 months of 2022 have whizzed by.

In third quarter of year 2022, I have collected the following passive streams of interests and dividends.

$117.50 Savings Bond (1 Jul)
$370.20 UOB (22 Aug)
$96 Sembcorp Ind (23 Aug)
$90 Wilmar (24 Aug) SRS
$456 Mapletree Com Trust (25 Aug)
$960.12 OCBC (25 Aug) SRS
$186.56 Ascott Trust (29 Aug)
$213.00 Comfortdelgro (29 Aug) SRS
$307.42 Keppel Reit (29 Aug) SRS
$120.95 Suntec Reit (29 Aug)
€169.20 ($234.35) IREIT Global (31 Aug)
$119.50 Savings Bond (1 Sep)
$188.00 ST Eng (2 Sep) SRS
$787.30 Ascendas Reit (5 Sep)
$939.60 Capland Int Com Trust (9 Sep)
$403.92 Keppel DC Reit (9 Sep) SRS
$286.80 (109 Shares) Mapletree Ind Trust DRP (9 Sep)
$226.80 Mapletree Log Trust (9 Sep)
$211.31 (182 Shares) Capitaland China Trust DRP (22 Sep)
$729.60 Aims Apac Reit (23 Sep)
$42 OUE (29 Sep)

The total amount of passive income in Q3 2022 is $7,086.93, a 48% YoY increase from Q3 2021's $4,740.77.

Together with the $9,903.18 passive income in the first half of 2022, my passive income in the first 9 months of 2022 is


Time in the market beats timing the market. I am happy to remain primarily invested locally in SGX for passive income, while having a little exposure to US tech stocks for selling put options to collect premiums.

My ultimate goal is to own an investment portfolio valued at one million dollars yielding at least $50k of passive income annually. Currently, I am at less than half of the journey as my SGX income portfolio and SRS ultra long-term portfolios are valued at around $400K and dividends are projected to be around $20k for this year.

My motto is to live frugally, save up, invest in any bear or bull market conditions, slowly and steadily build up my investments.

I look forward to collecting more dividends as passive income in the final quarter of Year 2022.

Thanks for reading. Stay focused and remain steadfast as always! Huat ah!

With love and peace, 

No comments: